Joanna Vergidis
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 8
- Cancer, Lipids, and Metabolism 3
-
- Prostate Cancer Treatment and Research 21
- Prostate Cancer Diagnosis and Treatment 4
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 4
- CAR-T cell therapy research 2
- Colorectal Cancer Screening and Detection 2
-
- Radiopharmaceutical Chemistry and Applications 10
- Hematology top 10%
In The Last Decade
Joanna Vergidis
27 papers receiving 972 citations
Hit Papers
Peers
Comparison fields: 5 of 55
- Cancer Research 386
- Pulmonary and Respiratory Medicine 772
- Oncology 334
- Radiology, Nuclear Medicine and Imaging 201
- Hematology 73
Countries citing papers authored by Joanna Vergidis
This map shows the geographic impact of Joanna Vergidis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanna Vergidis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanna Vergidis more than expected).
Fields of papers citing papers by Joanna Vergidis
This network shows the impact of papers produced by Joanna Vergidis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanna Vergidis. The network helps show where Joanna Vergidis may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Joanna Vergidis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 2 | |
| 2 | 2021 | 52 | |
| 3 | 2021 | 11 | |
| 4 | 2019 | 213 | |
| 5 | Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancerbreakdown → | 2018 | 347 |
| 6 | 2018 | 58 | |
| 7 | 2018 | 16 | |
| 8 | 2018 | 1 | |
| 9 | 2018 | 1 | |
| 10 | 2018 | 8 | |
| 11 | 2017 | 3 | |
| 12 | 2017 | 31 | |
| 13 | 2017 | 9 | |
| 14 | 2016 | 3 | |
| 15 | 2016 | 2 | |
| 16 | 2016 | 9 | |
| 17 | 2015 | 9 | |
| 18 | 2015 | 18 | |
| 19 | 2013 | 1 | |
| 20 | 2005 | 88 |
About Joanna Vergidis
Joanna Vergidis is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology, having authored 27 papers that have together received 980 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (21 papers), Radiopharmaceutical Chemistry and Applications (10 papers), Cancer Genomics and Diagnostics (8 papers), Cancer Immunotherapy and Biomarkers (4 papers), Prostate Cancer Diagnosis and Treatment (4 papers), Cancer, Lipids, and Metabolism (3 papers), CAR-T cell therapy research (2 papers) and Colorectal Cancer Screening and Detection (2 papers). The work is most often cited by research in Cancer Research (386 citations), Pulmonary and Respiratory Medicine (772 citations) and Oncology (334 citations). Joanna Vergidis has collaborated with scholars based in Canada, Finland and Australia. Frequent co-authors include Kim N., Muhammad Zulfiqar, Daygen L. Finch, Daniel Khalaf, Martin Gleave, Conrad D. Oja, Bernhard J. Eigl, Katherine Sunderland, Christian Kollmannsberger and Alexander W. Wyatt. Their work appears in journals such as Journal of Clinical Oncology, Blood and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.